Skip to main content
Inventiva logo

Inventiva — Investor Relations & Filings

Ticker · IVA ISIN · FR0013233012 LEI · 969500I9Y690B3FZW590 PA Manufacturing
Open in API
Filings indexed 688 across all filing types
Latest filing 2020-07-10 Delisting Announcement
Country FR France
Listing PA IVA

About Inventiva

https://inventivapharma.com/

Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for diseases with significant unmet medical needs. The company's primary therapeutic areas include fibrotic diseases, lysosomal storage disorders, and oncology. Its lead product candidate, lanifibranor, is a pan-PPAR (peroxisome proliferator-activated receptor) agonist being evaluated in a pivotal Phase III clinical trial for the treatment of non-alcoholic steatohepatitis (NASH). Lanifibranor is designed to address the key features of NASH, including steatosis, inflammation, ballooning, and fibrosis. The candidate has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) based on positive Phase IIb results.

Recent filings

Filing Released Lang Actions
Inventiva annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris
Delisting Announcement Classification · 99% confidence The document is titled "COMMUNIQUE DE PRESSE" / "PRESS RELEASE" and announces a temporary suspension of trading on Euronext Paris pending the introduction of American Depositary Shares (ADSs) on the Nasdaq Global Market. This is a time-sensitive, material corporate action announcement related to financing/listing activities. It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A). Since it is a press release announcing a significant corporate event (listing/capital structure change), it best fits the 'Capital/Financing Update' category (CAP). It is too specific for the general 'Regulatory Filings' (RNS) fallback, and it is not merely an announcement of a report publication (RPA). The content strongly relates to the capital structure change associated with the US listing.
2020-07-10 French
Inventiva announces the pricing of its initial public offering on the Nasdaq Global Market
Share Issue/Capital Change Classification · 99% confidence The document is a press release announcing the pricing of an initial public offering (IPO) on the Nasdaq Global Market. It details the number of shares, the offering price, the use of proceeds, and the underwriting details. While it contains financial information, it is an announcement of a capital-raising event rather than a periodic financial report or a prospectus itself. Therefore, it falls under the category of Capital/Financing Update.
2020-07-10 English
Inventiva annonce le dépôt d'un « amendement » au document d'enregistrement (Form F-1) incluant une fourchette de prix indicative
Capital/Financing Update Classification · 98% confidence The document is explicitly titled a "PRESS RELEASE" announcing the filing of an amendment to a registration statement (Form F-1) to include an indicative price range for a proposed offering of American Depositary Shares (ADSs) and ordinary shares (the 'Global Offering'). This announcement details the structure of a financing/fundraising activity, including the use of proceeds, involvement of underwriters (Jefferies, Stifel, Guggenheim), and references to SEC filings (Form F-1) and European regulatory filings (Universal Registration Document with AMF). This clearly falls under the category of updates on company fundraising, financing activities, or capital structure changes. Based on the definitions: - It is not a 10-K (Annual Report). - It is not an ER (Earnings Release) or IR (Interim Report). - It is directly about raising capital/financing. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2020-07-08 French
Inventiva announces the filing of an amended registration statement, including an estimated initial public offering price range
Capital/Financing Update Classification · 99% confidence The document is a press release dated July 8, 2020, announcing the formal commencement of bookbuilding and the filing of an amended registration statement on Form F-1 in connection with an intended Initial Public Offering (IPO) of American Depositary Shares (ADSs) in the United States and a concurrent offering of ordinary shares in Europe (Global Offering). This announcement details the offering size, price range, underwriters, intended use of proceeds, and regulatory filings (Form F-1 with the SEC, and listing prospectus with the French AMF). This activity directly relates to the company raising capital through the issuance of new securities, which aligns perfectly with the definition of a Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2020-07-08 English
Inventiva annonce le début du roadshow dans le cadre de son projet d’Offre Globale et de son projet de cotation au Nasdaq
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled a "PRESS RELEASE" and announces the commencement of a roadshow related to a proposed Global Offering (Offre Globale) and a planned listing on Nasdaq. It details the number of shares/ADSs to be offered, mentions underwriters (Jefferies, Stifel, Guggenheim), and refers to filing a Form F-1 registration statement with the SEC and a prospectus with the AMF. This activity—announcing a public offering of securities (capital raising) and the associated roadshow—falls directly under the definition of a Capital/Financing Update.
2020-07-06 French
Inventiva Announces the Start of the Roadshow for its Proposed Global Offering and Proposed Nasdaq Listing
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled 'COMMUNIQUE DE PRESSE' (Press Release) and announces the 'Start of the Roadshow for its Proposed Global Offering and Proposed Nasdaq Listing.' It details the intention to issue and sell ordinary shares/ADSs in a U.S. Offering and a concurrent European Offering. This activity—raising capital through a public offering—falls directly under the definition of 'Capital/Financing Update' (CAP). Although it mentions that a registration statement on Form F-1 has been filed with the SEC and a listing prospectus subject to AMF approval is involved, the primary purpose of this specific document is the announcement of the financing event (the roadshow and offering), not the filing of the final prospectus or the full financial report itself. Therefore, CAP is the most appropriate classification.
2020-07-06 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.